Abstract
Summary
LPI (LP Information)' newest research report, the “Generic Allergy Medicine Industry Forecast” looks at past sales and reviews total world Generic Allergy Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Generic Allergy Medicine sales for 2023 through 2029. With Generic Allergy Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Allergy Medicine industry.
This Insight Report provides a comprehensive analysis of the global Generic Allergy Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Generic Allergy Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Allergy Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Allergy Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Allergy Medicine.
The global Generic Allergy Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Generic Allergy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Generic Allergy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Generic Allergy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Generic Allergy Medicine players cover Sanofi, Johnson & Johnson, Bayer, Matrixx Initiatives, AstraZeneca, GSK, Pfizer, Chattem and Astellas Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Allergy Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Antihistamine
Allergic Reaction Mediator (Mast Cell Stabilizer)
Calcium
Immunosuppressive Agent
Segmentation by application
Children
Adult
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Johnson & Johnson
Bayer
Matrixx Initiatives
AstraZeneca
GSK
Pfizer
Chattem
Astellas Pharma
Mylan Pharmaceuticals
Jiudian Pharmaceutical
This Insight Report provides a comprehensive analysis of the global Generic Allergy Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Generic Allergy Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Allergy Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Allergy Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Allergy Medicine.
The global Generic Allergy Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Generic Allergy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Generic Allergy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Generic Allergy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Generic Allergy Medicine players cover Sanofi, Johnson & Johnson, Bayer, Matrixx Initiatives, AstraZeneca, GSK, Pfizer, Chattem and Astellas Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Allergy Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Antihistamine
Allergic Reaction Mediator (Mast Cell Stabilizer)
Calcium
Immunosuppressive Agent
Segmentation by application
Children
Adult
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Johnson & Johnson
Bayer
Matrixx Initiatives
AstraZeneca
GSK
Pfizer
Chattem
Astellas Pharma
Mylan Pharmaceuticals
Jiudian Pharmaceutical
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Generic Allergy Medicine Market Size 2018-2029
2.1.2 Generic Allergy Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Generic Allergy Medicine Segment by Type
2.2.1 Antihistamine
2.2.2 Allergic Reaction Mediator (Mast Cell Stabilizer)
2.2.3 Calcium
2.2.4 Immunosuppressive Agent
2.3 Generic Allergy Medicine Market Size by Type
2.3.1 Generic Allergy Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Generic Allergy Medicine Market Size Market Share by Type (2018-2023)
2.4 Generic Allergy Medicine Segment by Application
2.4.1 Children
2.4.2 Adult
2.5 Generic Allergy Medicine Market Size by Application
2.5.1 Generic Allergy Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Generic Allergy Medicine Market Size Market Share by Application (2018-2023)
3 Generic Allergy Medicine Market Size by Player
3.1 Generic Allergy Medicine Market Size Market Share by Players
3.1.1 Global Generic Allergy Medicine Revenue by Players (2018-2023)
3.1.2 Global Generic Allergy Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Generic Allergy Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Generic Allergy Medicine by Regions
4.1 Generic Allergy Medicine Market Size by Regions (2018-2023)
4.2 Americas Generic Allergy Medicine Market Size Growth (2018-2023)
4.3 APAC Generic Allergy Medicine Market Size Growth (2018-2023)
4.4 Europe Generic Allergy Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa Generic Allergy Medicine Market Size Growth (2018-2023)
5 Americas
5.1 Americas Generic Allergy Medicine Market Size by Country (2018-2023)
5.2 Americas Generic Allergy Medicine Market Size by Type (2018-2023)
5.3 Americas Generic Allergy Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Allergy Medicine Market Size by Region (2018-2023)
6.2 APAC Generic Allergy Medicine Market Size by Type (2018-2023)
6.3 APAC Generic Allergy Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Generic Allergy Medicine by Country (2018-2023)
7.2 Europe Generic Allergy Medicine Market Size by Type (2018-2023)
7.3 Europe Generic Allergy Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Generic Allergy Medicine by Region (2018-2023)
8.2 Middle East & Africa Generic Allergy Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa Generic Allergy Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Generic Allergy Medicine Market Forecast
10.1 Global Generic Allergy Medicine Forecast by Regions (2024-2029)
10.1.1 Global Generic Allergy Medicine Forecast by Regions (2024-2029)
10.1.2 Americas Generic Allergy Medicine Forecast
10.1.3 APAC Generic Allergy Medicine Forecast
10.1.4 Europe Generic Allergy Medicine Forecast
10.1.5 Middle East & Africa Generic Allergy Medicine Forecast
10.2 Americas Generic Allergy Medicine Forecast by Country (2024-2029)
10.2.1 United States Generic Allergy Medicine Market Forecast
10.2.2 Canada Generic Allergy Medicine Market Forecast
10.2.3 Mexico Generic Allergy Medicine Market Forecast
10.2.4 Brazil Generic Allergy Medicine Market Forecast
10.3 APAC Generic Allergy Medicine Forecast by Region (2024-2029)
10.3.1 China Generic Allergy Medicine Market Forecast
10.3.2 Japan Generic Allergy Medicine Market Forecast
10.3.3 Korea Generic Allergy Medicine Market Forecast
10.3.4 Southeast Asia Generic Allergy Medicine Market Forecast
10.3.5 India Generic Allergy Medicine Market Forecast
10.3.6 Australia Generic Allergy Medicine Market Forecast
10.4 Europe Generic Allergy Medicine Forecast by Country (2024-2029)
10.4.1 Germany Generic Allergy Medicine Market Forecast
10.4.2 France Generic Allergy Medicine Market Forecast
10.4.3 UK Generic Allergy Medicine Market Forecast
10.4.4 Italy Generic Allergy Medicine Market Forecast
10.4.5 Russia Generic Allergy Medicine Market Forecast
10.5 Middle East & Africa Generic Allergy Medicine Forecast by Region (2024-2029)
10.5.1 Egypt Generic Allergy Medicine Market Forecast
10.5.2 South Africa Generic Allergy Medicine Market Forecast
10.5.3 Israel Generic Allergy Medicine Market Forecast
10.5.4 Turkey Generic Allergy Medicine Market Forecast
10.5.5 GCC Countries Generic Allergy Medicine Market Forecast
10.6 Global Generic Allergy Medicine Forecast by Type (2024-2029)
10.7 Global Generic Allergy Medicine Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Generic Allergy Medicine Product Offered
11.1.3 Sanofi Generic Allergy Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Generic Allergy Medicine Product Offered
11.2.3 Johnson & Johnson Generic Allergy Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Generic Allergy Medicine Product Offered
11.3.3 Bayer Generic Allergy Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Matrixx Initiatives
11.4.1 Matrixx Initiatives Company Information
11.4.2 Matrixx Initiatives Generic Allergy Medicine Product Offered
11.4.3 Matrixx Initiatives Generic Allergy Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Matrixx Initiatives Main Business Overview
11.4.5 Matrixx Initiatives Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Generic Allergy Medicine Product Offered
11.5.3 AstraZeneca Generic Allergy Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 GSK
11.6.1 GSK Company Information
11.6.2 GSK Generic Allergy Medicine Product Offered
11.6.3 GSK Generic Allergy Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GSK Main Business Overview
11.6.5 GSK Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Generic Allergy Medicine Product Offered
11.7.3 Pfizer Generic Allergy Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Chattem
11.8.1 Chattem Company Information
11.8.2 Chattem Generic Allergy Medicine Product Offered
11.8.3 Chattem Generic Allergy Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Chattem Main Business Overview
11.8.5 Chattem Latest Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Information
11.9.2 Astellas Pharma Generic Allergy Medicine Product Offered
11.9.3 Astellas Pharma Generic Allergy Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Astellas Pharma Main Business Overview
11.9.5 Astellas Pharma Latest Developments
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Information
11.10.2 Mylan Pharmaceuticals Generic Allergy Medicine Product Offered
11.10.3 Mylan Pharmaceuticals Generic Allergy Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Mylan Pharmaceuticals Main Business Overview
11.10.5 Mylan Pharmaceuticals Latest Developments
11.11 Jiudian Pharmaceutical
11.11.1 Jiudian Pharmaceutical Company Information
11.11.2 Jiudian Pharmaceutical Generic Allergy Medicine Product Offered
11.11.3 Jiudian Pharmaceutical Generic Allergy Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Jiudian Pharmaceutical Main Business Overview
11.11.5 Jiudian Pharmaceutical Latest Developments
12 Research Findings and Conclusion